Description

According to a report by StrategyHelix, the global tmj disorders market is set to increase by US$ 157.3 million during 2022-2028, growing at a CAGR of 4.4% during the forecast period.

The report provides up-to-date market size data for period 2018-2021 and forecast to 2028 covering key market aspects like sales value for tmj disorders. The global tmj disorders market is segmented on the basis of type, treatment, end user, and region. On the basis of type, the global tmj disorders market has been segmented into arthritis, internal derangement, myofascial pain. By treatment, the global tmj disorders market has been segmented into medication, surgeries, therapies, others. Based on end user, the global tmj disorders market is categorized into academic and research institutes, ambulatory surgery centers (ASCs), hospitals & clinics, others. Geographically, the global tmj disorders market is segmented into North America, Asia Pacific, Europe, Rest of the World (ROW).

The global tmj disorders market is highly competitive. The prominent players operating in the global tmj disorders market include Abbott Laboratories, Allergan plc (AbbVie Inc.), Bayer AG, Jubilant Life Sciences Ltd., Mylan N.V., Novartis AG, Sun Pharmaceutical Industries Ltd., Teva Pharmaceutical Industries Ltd., The Bristol-Myers Squibb Company, Zydus Lifesciences Limited.

The report is an invaluable resource for companies and organizations active in this industry. It provides a cohesive picture of the tmj disorders market to help drive informed decision making for industry executives, policy makers, academic, and analysts.

Report Scope

Type: arthritis, internal derangement, myofascial pain
Treatment: medication, surgeries, therapies, others
End user: academic and research institutes, ambulatory surgery centers (ASCs), hospitals & clinics, others
Region: North America, Asia Pacific, Europe, Rest of the World (ROW)
Years considered: this report covers the period 2018 to 2028

Key Benefits for Stakeholders

– Get a comprehensive picture of the global tmj disorders market
– Pinpoint growth sectors and trends for investment

Table of Contents

Part 1. Introduction
– Scope of the study
– Study period
– Geographical scope
– Research methodology
Part 2. Tmj disorders market overview
Part 3. Market breakdown by type
– Arthritis
– Internal derangement
– Myofascial pain
Part 4. Market breakdown by treatment
– Medication
– Surgeries
– Therapies
– Others
Part 5. Market breakdown by end user
– Academic and research institutes
– Ambulatory surgery centers (ASCs)
– Hospitals & clinics
– Others
Part 6. Market breakdown by region
– North America
– Asia Pacific
– Europe
– Rest of the World (ROW)
Part 7. Key companies
– Abbott Laboratories
– Allergan plc (AbbVie Inc.)
– Bayer AG
– Jubilant Life Sciences Ltd.
– Mylan N.V.
– Novartis AG
– Sun Pharmaceutical Industries Ltd.
– Teva Pharmaceutical Industries Ltd.
– The Bristol-Myers Squibb Company
– Zydus Lifesciences Limited
About StrategyHelix
Disclaimer